Ablation therapy for Barrett's columnar-lined esophagus

Problems in General Surgery

Volumn 18, Issue 2, 2001, Pages 85-93

  Bremner, R M ^a   Bremner, C G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; CARBOCYANINE; CYTOKINE; DNA; ETIOPURPURIN; HEAT SHOCK PROTEIN; HEMATOPORPHYRIN; HEMOGLOBIN; INTERLEUKIN 8; LANSOPRAZOLE; MESSENGER RNA; OMEPRAZOLE; PHOSPHOLIPASE; PHOTOFRIN; PHOTOFRIN II; POTASSIUM DERIVATIVE; PROTON PUMP INHIBITOR; PROTOPORPHYRIN; SINGLET OXYGEN; TALAPORFIN;

ANTIREFLUX OPERATION; ARGON LASER; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL TRIAL; COLUMNAR EPITHELIUM; DYE LASER; ELECTROCOAGULATION; ELECTROSURGERY; ENDOSCOPIC SURGERY; ESOPHAGUS CANCER; ESOPHAGUS PH; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HUMAN; INFLAMMATION; LASER SURGERY; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; STOMACH FUNDOPLICATION; ULTRASOUND THERAPY;

EID: 0035676404     PISSN: 07398328     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013452-200106000-00011     Document Type: Review

References (53)

1. Ablative therapies for the columnar-lined esophagus
2. Repeat laser therapy of recurrent Barrett's epithelium: Success with anacidity
3. Ultrasonic epithelial ablation of the lower esophagus without stricture formation
4. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results
5. Successful reversal of Barrett's esophagus with multi-polar electrocoagulation despite inadequate acid suppression
6. Regression of childhood Barrett's esophageal mucosa by antireflux surgery and bipolar electrocoagulation
7. Efficacy and safety of reversal of Barrett's esophagus with highdose omeprazole and electrocoagulation
8. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive antireflux therapy
9. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression
10. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus
11. Fundamentals of laser surgery
12. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium
13. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous reepithelialisation
14. Endoscopic laser ablation of Barrett's mucosa followed by Nissen fundoplication: Results of a pilot study
15. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery
16. Photodynamic therapy
17. Autoradiographic distribution of hematoporphrin derivative in normal and tumor tissue of the mouse
18. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy
19. Photodynamic therapy for esophageal cancer using a 180° windowed esophageal balloon
20. Endogenous proporphyrin IX: A clinically useful photosensitizer for photodynamic therapy
21. Photodynamic therapy of Barrett's esophagus after local administration of 5-aminolevulinic acid
22. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus
23. Endoscopic treatment of esophagogastric tumors
24. Clinical course of photodynamic therapy indirect esophageal strictures
25. High-grade dysplasia in the columnar-lined esophagus
26. Photodynamic therapy alone or with thermal ablation eliminates Barrett's esophagus
27. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
28. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid
29. Eradication of highgrade dysplasia in columnar-lined (Barrett's) oesophagus by photodaynamic therapy with endogenously generated protoporphyrin IX
30. Clinical photodynamic therapy for superficial cancer in the oesophagus and bronchi: 514 nm compared with 630 nm light irradiation after sensitization with photofrin
31. Photodynamic therapy for high-grade dysplasia and early adenocarcinoma of the esophago-gastric junction and gastric cardia in elderly patients with short-segment Barrett's esophagus
32. Photodynamic therapy with 5-aminolaevulinic acid for the treatment of dysplasia and early carcinoma in the upper GI tract
33. Resection for Barrett's mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy
34. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YGA laser for palliation of esophageal cancer: A multicenter randomized trial
35. DNA or cell kinetics flow cytometry. Analysis of 33 small gastrointestinal cancers treated by photodynamic therapy
36. Photodynamic therapy in early gastrointestinal cancer
37. Photodynamic therapy for high-grade dysplasia and adenocarcinoma in Barrett's oesophagus using photosensitisation with amino-laevulinic acids
38. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5-aminolae-vulinic acid induced protoporphyrin IX: A pilot study
39. Photodynamic therapy for esophageal tumors
40. Photodynamic therapy for endobronchial and esophageal tumors: An overview
41. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation
42. A detailed analysis of the pattern of neosquamous epithelium following endoscopic argon beam plasma coagulation of Barrett's esophagus
43. Endoscopic argon plasma coagulation (APC): First clinical experiences in flexible endoscopy
44. Endoscopic therapy of Barrett's esophagus using argon-plasmacoagulation (APC)
45. Argon plasma coagulation (APC) in patients with Barrett's esophagus
46. Regeneration of squamous mucosa after argon plasma coagulation (APC) of Barrett's epithelium
47. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid-term results
48. Argon plasma coagulation for ablation of Barrett's epithelium: First clinical results in 21 patients
49. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus
50. Reconstitution of squamous epithelium in Barrett's esophagus with endoscopic argon plasma coagulation: A prospective study
51. Endoscopic mucosal resection for esophageal and gastric mucosal cancers
52. Endoscopic resection of "low-risk" Barrett's carcinomas
53. Ablation therapy of Barrett's esophagus measures of success and failure